Neumora Therapeutics (NMRA) Stock Chart & Stock Price History → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free NMRA Stock Alerts $9.67 +0.04 (+0.42%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Neumora Therapeutics Stock Price Performance5 Day Performance0.00%1 Month Performance-5.01%3 Month Performance-47.56%6 Month Performance-18.40%Year-To-Date Performance-43.28% Ad InvestorPlaceHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs NMRA Stock Chart for Monday, May, 20, 2024 NMRA Chart by TradingView Neumora Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$9.63$9.67+0.42%$9.70$9.38320,321 shs$1.54 billion05/16/2024$9.67$9.63-0.41%$9.75$9.44440,266 shs$1.54 billion05/15/2024$9.58$9.67+0.94%$9.71$9.36684,072 shs$1.54 billion05/14/2024$8.96$9.58+6.92%$9.62$8.90588,266 shs$1.53 billion05/13/2024$9.19$8.96-2.50%$9.46$8.90717,533 shs$1.43 billion05/10/2024$9.77$9.19-5.94%$9.85$9.02292,661 shs$1.47 billionShocking: One AI startup's revenue could surge 4,735% (Ad)Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company05/09/2024$9.42$9.77+3.72%$10.15$9.33411,601 shs$1.56 billion05/08/2024$9.81$9.42-3.98%$9.82$9.13428,339 shs$1.50 billion05/07/2024$9.35$9.81+4.92%$9.91$9.00483,967 shs$1.56 billion05/06/2024$9.25$9.35+1.08%$9.42$9.00441,583 shs$1.49 billion05/03/2024$9.22$9.25+0.33%$9.66$9.21378,314 shs$1.47 billion05/02/2024$9.10$9.22+1.32%$9.27$8.841.07 million shs$1.47 billion05/01/2024$9.09$9.10+0.11%$9.49$8.90499,254 shs$1.45 billion04/30/2024$9.46$9.09-3.91%$9.62$9.04283,533 shs$1.45 billion04/29/2024$9.15$9.46+3.39%$9.74$9.19410,798 shs$1.51 billion04/26/2024$9.06$9.15+0.99%$9.31$8.82677,265 shs$1.45 billion04/25/2024$9.59$9.06-5.53%$9.81$8.98803,509 shs$1.44 billion04/24/2024$10.30$9.59-6.89%$10.47$9.48598,684 shs$1.52 billion04/23/2024$10.41$10.30-1.06%$10.74$10.29328,667 shs$1.64 billion04/22/2024$10.18$10.41+2.26%$10.70$9.98487,040 shs$1.65 billion04/19/2024$10.55$10.18-3.51%$10.72$9.96784,213 shs$1.62 billion04/18/2024$10.47$10.55+0.76%$10.91$10.22404,261 shs$1.68 billion04/17/2024$10.96$10.47-4.47%$11.27$10.24606,855 shs$1.74 billion04/16/2024$11.19$10.96-2.06%$11.65$10.90745,132 shs$1.74 billion04/15/2024$13.56$11.19-17.48%$12.35$10.731.99 million shs$1.78 billion04/12/2024$14.01$13.56-3.21%$13.97$13.44231,162 shs$2.15 billion04/11/2024$14.67$14.01-4.50%$14.75$13.58462,480 shs$2.23 billion04/10/2024$14.54$14.67+0.89%$14.71$14.01469,393 shs$2.33 billion04/09/2024$14.70$14.54-1.09%$14.95$14.26482,309 shs$2.31 billion04/08/2024$14.33$14.70+2.58%$14.87$13.94569,194 shs$2.34 billion04/05/2024$13.73$14.33+4.37%$14.66$13.59726,639 shs$2.28 billion04/04/2024$13.30$13.73+3.23%$14.17$13.22379,925 shs$2.18 billion04/03/2024$13.77$13.30-3.41%$14.21$12.97550,748 shs$2.11 billion04/02/2024$13.94$13.77-1.22%$14.03$13.12660,483 shs$2.19 billion04/01/2024$13.75$13.94+1.38%$14.67$13.60923,356 shs$2.21 billion03/29/2024$13.75$13.75$13.83$12.60960,306 shs$2.18 billion03/28/2024$12.61$13.75+9.04%$13.83$12.60960,306 shs$2.18 billion03/27/2024$12.61$12.61$13.21$12.48923,880 shs$2.00 billion03/26/2024$12.44$12.61+1.37%$13.10$12.36455,369 shs$2.00 billion03/25/2024$13.21$12.44-5.83%$13.32$12.251.55 million shs$1.98 billionShocking: One AI startup's revenue could surge 4,735% (Ad)Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company03/22/2024$13.98$13.21-5.51%$14.05$13.001.05 million shs$2.10 billion03/21/2024$13.99$13.98-0.07%$14.22$13.56790,273 shs$2.22 billion03/20/2024$14.03$13.99-0.29%$14.41$13.86656,545 shs$2.22 billion03/19/2024$14.16$14.03-0.92%$14.77$13.781.39 million shs$2.23 billion03/18/2024$15.09$14.16-6.16%$15.04$14.021.01 million shs$2.25 billion03/15/2024$15.13$15.09-0.26%$15.87$14.94647,792 shs$2.40 billion03/14/2024$14.81$15.13+2.16%$15.35$14.36887,568 shs$2.40 billion03/13/2024$17.35$14.81-14.64%$16.12$13.413.84 million shs$2.35 billion03/12/2024$18.05$17.35-3.88%$18.61$17.33820,529 shs$2.76 billion03/11/2024$18.00$18.05+0.28%$18.46$17.56262,531 shs$2.87 billion03/08/2024$19.00$18.00-5.26%$21.00$17.83409,427 shs$2.75 billion03/07/2024$18.40$19.00+3.26%$19.46$18.38116,974 shs$2.90 billion03/06/2024$17.32$18.40+6.24%$18.49$17.29267,746 shs$2.81 billion03/05/2024$17.38$17.32-0.35%$17.67$16.66182,070 shs$2.64 billion03/04/2024$18.05$17.38-3.71%$18.94$17.26160,379 shs$2.65 billion03/01/2024$17.63$18.05+2.38%$18.22$17.25422,372 shs$2.76 billion02/29/2024$17.69$17.63-0.34%$18.67$17.14354,857 shs$2.69 billion02/28/2024$18.57$17.69-4.74%$18.90$17.25340,561 shs$2.70 billion02/27/2024$18.54$18.57+0.16%$19.18$18.09258,965 shs$2.84 billion02/26/2024$19.28$18.54-3.84%$19.49$18.09237,172 shs$2.83 billion02/23/2024$18.82$19.28+2.44%$19.67$18.62192,497 shs$2.94 billion02/22/2024$17.99$18.82+4.61%$19.36$17.63223,009 shs$2.87 billion02/21/2024$18.44$17.99-2.44%$18.66$17.75265,402 shs$2.75 billion02/20/2024$19.76$18.44-6.68%$19.77$18.03310,496 shs$2.82 billion02/19/2024$19.76$19.76$19.82$18.47197,000 shs$3.02 billion Related Companies: ADMA Biologics Stock Chart Sana Biotechnology Stock Chart 4D Molecular Therapeutics Stock Chart Inhibrx Stock Chart Fusion Pharmaceuticals Stock Chart Tarsus Pharmaceuticals Stock Chart Vir Biotechnology Stock Chart Beam Therapeutics Stock Chart Cullinan Oncology Stock Chart Scholar Rock Stock Chart This page (NASDAQ:NMRA) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsBiden Nomination CANCELED?The Freeport Society Adding Choose a watchlist: Watchlist My Default Watchlist Adding Neumora Therapeutics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.